StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pharma-Bio Serv's revenue for the twelve months ending Jul 31, 2026 was $9.48M, up 3.3% year over year. For fiscal 2025 it was $9.00M, down 5.3% from the year before. Over ten years it grew -9.1% a year on average. The highest annual figure on record is $33.06M in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2025Oct 31, 2025$9.00M-5.3%
FY2024Oct 31, 2024$9.51M-44.0%
FY2023Oct 31, 2023$16.98M-12.5%
FY2022Oct 31, 2022$19.40M-3.6%
FY2021Oct 31, 2021$20.12M-6.7%
FY2020Oct 31, 2020$21.56M+10.5%
FY2019Oct 31, 2019$19.51M+9.6%
FY2018Oct 31, 2018$17.80M+33.8%
FY2017Oct 31, 2017$13.30M-31.9%
FY2016Oct 31, 2016$19.54M-16.5%
FY2015Oct 31, 2015$23.38M-15.1%
FY2014Oct 31, 2014$27.56M-16.7%
FY2013Oct 31, 2013$33.06M+13.1%
FY2012Oct 31, 2012$29.23M+46.6%
FY2011Oct 31, 2011$19.93M+75.7%
FY2010Oct 31, 2010$11.35M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$2.34M+19.0%
Q2 FY2026CQ1 2026Apr 30, 2026$2.70M+11.8%
Q1 FY2026CQ4 2025Jan 31, 2026$2.29M-7.1%
Q4 FY2025CQ3 2025Oct 31, 2025$2.15M-7.9%
Q3 FY2025CQ2 2025Jul 31, 2025$1.96M-18.8%
Q2 FY2025CQ1 2025Apr 30, 2025$2.42M+1.7%
Q1 FY2025CQ4 2024Jan 31, 2025$2.47M+3.8%
Q4 FY2024CQ3 2024Oct 31, 2024$2.33M-35.2%
Q3 FY2024CQ2 2024Jul 31, 2024$2.42M-47.2%
Q2 FY2024CQ1 2024Apr 30, 2024$2.38M-47.9%
Q1 FY2024CQ4 2023Jan 31, 2024$2.38M-43.8%
Q4 FY2023CQ3 2023Oct 31, 2023$3.60M-75.6%
Q3 FY2023CQ2 2023Jul 31, 2023$4.58M-18.2%
Q2 FY2023CQ1 2023Apr 30, 2023$4.56M-8.5%
Q1 FY2023CQ4 2022Jan 31, 2023$4.24M-15.9%
Q1 FY2022CQ4 2021Jul 31, 2022$14.76M+228.9%
Q4 FY2021CQ3 2021Oct 31, 2021$5.60M+11.4%
Q3 FY2021CQ2 2021Jul 31, 2021$4.99M-20.6%
Q2 FY2021CQ1 2021Apr 30, 2021$5.04M-10.7%
Q1 FY2021CQ4 2020Jan 31, 2021$4.49M-2.7%
Q4 FY2020CQ3 2020Oct 31, 2020$5.03M+4.2%
Q3 FY2020CQ2 2020Jul 31, 2020$6.28M+26.4%
Q2 FY2020CQ1 2020Apr 30, 2020$5.65M+9.7%
Q1 FY2020CQ4 2019Jan 31, 2020$4.61M+1.0%
Q4 FY2019CQ3 2019Oct 31, 2019$4.82M-15.0%
Q3 FY2019CQ2 2019Jul 31, 2019$4.97M+7.2%
Q2 FY2019CQ1 2019Apr 30, 2019$5.15M+36.8%
Q1 FY2019CQ4 2018Jan 31, 2019$4.57M+22.5%
Q4 FY2018CQ3 2018Oct 31, 2018$5.67M+320.3%
Q3 FY2018CQ2 2018Jul 31, 2018$4.63M+16.4%
Q2 FY2018CQ1 2018Apr 30, 2018$3.77M-4.0%
Q1 FY2018CQ4 2017Jan 31, 2018$3.73M-7.9%
Q4 FY2017CQ3 2017Oct 31, 2017$1.35M-70.9%
Q3 FY2017CQ2 2017Jul 31, 2017$3.98M-18.2%
Q2 FY2017CQ1 2017Apr 30, 2017$3.92M–
Q1 FY2017CQ4 2016Jan 31, 2017$4.05M–
Q4 FY2016CQ3 2016Oct 31, 2016$4.64M–
Q3 FY2016CQ2 2016Jul 31, 2016$4.87M–

More Pharma-Bio Serv figures

See a number that looks wrong?